POLAR CAPITAL GLOBAL HEALTH.TST PLC

Director's Dealing • Jul 23, 2020

National Storage Mechanism | Additional information

RNS Number : 9287T

Polar Capital Global Health Tst PLC

23 July 2020

Polar Capital Global Healthcare Trust plc (the "Company")

Legal Entity Identifier: 549300YV7J2TWLE7PV84 

Notification of Transactions by Persons Discharging Managerial Responsibilities (PDMRs)/Persons Closely Associated (PCAs)

The Company was notified on 23 July 2020 that Jeremy Whitley, a Non-executive Director, bought 10,000 Ordinary Shares of 25p each for his personal holding at the aggregate price of 254.6999pence per share. Following this transaction, Mr. Whitley is interested in a total of 20,000 Ordinary Shares representing approximately 0.016% of the Company's issued share capital.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Jeremy Whitley
2	Reason for the notification
a)	Position/status	Non-executive Director
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Polar Capital Global Healthcare Trust plc
b)	LEI	549300YV7J2TWLE7PV84
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of 25p each
Identification code	GB00B6832P16
b)	Nature of the transaction	Purchase
c)	Price(s) and volume(s)
		Price(s)	Volume(s)
		254.6999 pence per share	10,000
d)	Aggregated information	Single transaction as in 4 c) above
- Aggregated volume	10,000
- Price	£25,469.99
e)	Date of the transaction	23 July 2020
f)	Place of the transaction	London Stock Exchange (XLON)

Enquiries:

Tracey Lago, FCG

Company Secretary

Polar Capital Global Healthcare Trust plc

Telephone Number: 020 7227 2700

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBXGDRBXDDGGX